NOTE: The governor signed this measure on 5/11/2015.
      
      
      HOUSE BILL 15-1214
      
      
      BY REPRESENTATIVE(S) Singer, Duran, Fields, Ginal, Lontine,
      McCann, Pettersen, Rosenthal, Ryden, Tyler, Moreno, Primavera;
      also SENATOR(S) Cooke, Todd.
      
      
      Concerning opioid analgesics with abuse-deterrent properties.
      
      
      Be it enacted by the General Assembly of the State of Colorado:
      
           SECTION 1.  In Colorado Revised Statutes, add 10-16-124.7 as
      follows:
      
           10-16-124.7. Opioid analgesics with abuse-deterrent properties
      - study - definitions. (1)  The governor shall direct the Colorado
      consortium for prescription drug abuse prevention to study the
      barriers to the use of abuse-deterrent opioid analgesic drug
      products as a way to reduce abuse and diversion of opioid drug
      products. On or before January 15, 2017, the consortium shall
      report its findings to the public health care and human services
      committee and the health, insurance, and environment committee
      of the house of representatives and the health and human
      services committee of the senate, or their successor committees.
      
           (2)  Moneys from the general fund shall not be used for the
      implementation of this section.
      
           (3)  As used in this section:
      
           (a)  "Abuse-deterrent opioid analgesic drug product" means
      a brand or generic opioid analgesic drug product approved by the
      United States food and drug administration with
      abuse-deterrence labeling claims that indicate that the drug
      product is expected to result in a meaningful reduction in abuse.
      
           (b)  "Opioid analgesic drug product" means a drug product
      in the opioid analgesic drug class prescribed to treat moderate
      to severe pain or other conditions, whether in immediate release
      or extended release or long-acting form, that may be combined
      with other drug substances to form a single drug product or
      dosage form.
      
           SECTION 2.  Safety clause. The general assembly hereby finds,
      determines, and declares that this act is necessary for the immediate
      preservation of the public peace, health, and safety.
      
      
      
      
      ________________________________________________________
      Dickey Lee Hullinghorst                Bill L. Cadman
      SPEAKER OF THE HOUSE                     PRESIDENT OF
      OF REPRESENTATIVES                         THE SENATE
      
      
      
      
      
      
      ____________________________  ____________________________
      Marilyn Eddins                      Cindi L. Markwell
      CHIEF CLERK OF THE HOUSE                 SECRETARY OF
      OF REPRESENTATIVES                         THE SENATE
      
      
      
      
                  APPROVED________________________________________
      
      
      
      
      
                                    _________________________________________
                                    John W. Hickenlooper
                                    GOVERNOR OF THE STATE OF COLORADO